Therefore, the above results suggest that HSPH1 can be used as an independent prognostic factor in NSCLC patients, and its high expression often represents a poor prognosis for patients, so HSPH1 has great potential to become a prognostic marker for NSCLC. The gene discussed is HSPH1; the disease is non-small cell lung carcinoma.